07. August 2017
Metformin is an oral hypoglycemic agent used in the type 2 diabetes, whose poor bioavailability and short half-life make the development of effective extended-release formulations highly desirable.
19. June 2017
The oral route as a means of drug delivery and immunisation offers a range of advantages including ease of administration, reduced need for trained personnel to administer vaccines and generally an increased convenience and compliance.